Generics Global Industry Guide 2013-2022

  • ID: 4663784
  • Report
  • Region: Global
  • 263 pages
  • MarketLine
1 of 3
Generics Global Industry Guide 2013-2022

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Questions Answered:
  • What was the size of the global generics market by value in 2017?
  • What will be the size of the global generics market in 2022?
  • What factors are affecting the strength of competition in the global generics market?
  • How has the market performed over the last five years?
  • How large is the global generics market in relation to its regional counterparts?
Scope
  • Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The market value is evaluated at ex-factory prices.
  • Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
  • Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
  • Note that any volumes of 1" (one) or 100% are due to rounding as the researcher does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
EXECUTIVE SUMMARY
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global Generics
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Generics in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Generics in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Generics in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Generics in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading Companies
Appendix
Methodology
About the Author

List of Tables
Table 1: Global generics market value: $ billion, 2013-17
Table 2: Global generics market volume: % of total pharma, 2013-17
Table 3: Global generics market geography segmentation: $ billion, 2017
Table 4: Global generics market value forecast: $ billion, 2017-22
Table 5: Global generics market volume forecast: % of total pharma, 2017-22
Table 6: Asia-Pacific generics market value: $ billion, 2013-17
Table 7: Asia-Pacific generics market volume: % of total pharma, 2013-17
Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2017
Table 9: Asia-Pacific generics market value forecast: $ billion, 2017-22
Table 10: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
Table 11: Europe generics market value: $ billion, 2013-17
Table 12: Europe generics market volume: % of total pharma, 2013-17
Table 13: Europe generics market geography segmentation: $ billion, 2017
Table 14: Europe generics market value forecast: $ billion, 2017-22
Table 15: Europe generics market volume forecast: % of total pharma, 2017-22
Table 16: France generics market value: $ million, 2013-17
Table 17: France generics market volume: % of total pharma, 2013-17
Table 18: France generics market geography segmentation: $ million, 2017
Table 19: France generics market value forecast: $ million, 2017-22
Table 20: France generics market volume forecast: % of total pharma, 2017-22
Table 21: France size of population (million), 2013-17
Table 22: France gdp (constant 2005 prices, $ billion), 2013-17
Table 23: France gdp (current prices, $ billion), 2013-17
Table 24: France inflation, 2013-17
Table 25: France consumer price index (absolute), 2013-17
Table 26: France exchange rate, 2013-17
Table 27: Germany generics market value: $ million, 2013-17
Table 28: Germany generics market volume: % of total pharma, 2013-17
Table 29: Germany generics market geography segmentation: $ million, 2017
Table 30: Germany generics market value forecast: $ million, 2017-22
Table 31: Germany generics market volume forecast: % of total pharma, 2017-22
Table 32: Germany size of population (million), 2013-17
Table 33: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 34: Germany gdp (current prices, $ billion), 2013-17
Table 35: Germany inflation, 2013-17
Table 36: Germany consumer price index (absolute), 2013-17
Table 37: Germany exchange rate, 2013-17
Table 38: Italy generics market value: $ million, 2013-17
Table 39: Italy generics market volume: % of total pharma, 2013-17
Table 40: Italy generics market geography segmentation: $ million, 2017
Table 41: Italy generics market value forecast: $ million, 2017-22
Table 42: Italy generics market volume forecast: % of total pharma, 2017-22
Table 43: Italy size of population (million), 2013-17
Table 44: Italy gdp (constant 2005 prices, $ billion), 2013-17
Table 45: Italy gdp (current prices, $ billion), 2013-17
Table 46: Italy inflation, 2013-17
Table 47: Italy consumer price index (absolute), 2013-17
Table 48: Italy exchange rate, 2013-17
Table 49: Japan generics market value: $ million, 2013-17
Table 50: Japan generics market volume: % of total pharma, 2013-17

List of Figures
Figure 1: Global generics market value: $ billion, 2013-17
Figure 2: Global generics market volume: % of total pharma, 2013-17
Figure 3: Global generics market geography segmentation: % share, by value, 2017
Figure 4: Global generics market value forecast: $ billion, 2017-22
Figure 5: Global generics market volume forecast: % of total pharma, 2017-22
Figure 6: Forces driving competition in the global generics market, 2017
Figure 7: Drivers of buyer power in the global generics market, 2017
Figure 8: Drivers of supplier power in the global generics market, 2017
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2017
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2017
Figure 11: Drivers of degree of rivalry in the global generics market, 2017
Figure 12: Asia-Pacific generics market value: $ billion, 2013-17
Figure 13: Asia-Pacific generics market volume: % of total pharma, 2013-17
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2017
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2017-22
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma, 2017-22
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2017
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2017
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2017
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2017
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2017
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2017
Figure 23: Europe generics market value: $ billion, 2013-17
Figure 24: Europe generics market volume: % of total pharma, 2013-17
Figure 25: Europe generics market geography segmentation: % share, by value, 2017
Figure 26: Europe generics market value forecast: $ billion, 2017-22
Figure 27: Europe generics market volume forecast: % of total pharma, 2017-22
Figure 28: Forces driving competition in the generics market in Europe, 2017
Figure 29: Drivers of buyer power in the generics market in Europe, 2017
Figure 30: Drivers of supplier power in the generics market in Europe, 2017
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2017
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2017
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2017
Figure 34: France generics market value: $ million, 2013-17
Figure 35: France generics market volume: % of total pharma, 2013-17
Figure 36: France generics market geography segmentation: % share, by value, 2017
Figure 37: France generics market value forecast: $ million, 2017-22
Figure 38: France generics market volume forecast: % of total pharma, 2017-22
Figure 39: Forces driving competition in the generics market in France, 2017
Figure 40: Drivers of buyer power in the generics market in France, 2017
Figure 41: Drivers of supplier power in the generics market in France, 2017
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2017
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2017
Figure 44: Drivers of degree of rivalry in the generics market in France, 2017
Figure 45: Germany generics market value: $ million, 2013-17
Figure 46: Germany generics market volume: % of total pharma, 2013-17
Figure 47: Germany generics market geography segmentation: % share, by value, 2017
Figure 48: Germany generics market value forecast: $ million, 2017-22
Figure 49: Germany generics market volume forecast: % of total pharma, 2017-22
Figure 50: Forces driving competition in the generics market in Germany, 2017
Figure 51: Drivers of buyer power in the generics market in Germany, 2017
Figure 52: Drivers of supplier power in the generics market in Germany, 2017
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2017
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2017
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll